What You Should Know:
– Delfina Care, a healthcare technology company addressing the maternal health crisis raises $17M in Series A funding round led by U.S. Venture Partners (USVP) with included participation from ARTIS Ventures, Mayo Clinic, Tokio Marine Future Fund, Story Ventures, SemperVirens, Bread and Butter Ventures, Boutique Ventures, and Chelsea Clinton’s Metrodora Ventures.
– The investment will fuel Delfina’s growth and expansion, enabling the company to deliver its AI-powered care platform to more women and improve maternal and infant health outcomes.
The Maternal Health Crisis
The United States is facing a maternal health crisis, with maternal mortality rates significantly higher than other high-income countries. Black women are disproportionately affected, experiencing maternal mortality rates nearly three times higher than white women and a preterm birth rate 1.4 times higher. Addressing this crisis requires a multi-faceted approach that includes better access to quality maternal care, addressing social determinants of health, and leveraging technology to improve outcomes.
Maternal Health with AI-Powered Proactive Care
Founded in 2019, Delfina partners with payors, providers, and community organizations to deliver equitable, data-driven maternal health support. By empowering prenatal care teams with actionable insights and reducing disparities, Delfina is helping to create a healthier future for mothers and babies. Delfina’s AI-powered platform addresses the maternal health crisis by combining predictive analytics, tailored interventions, and enhanced communication between patients and providers. The platform’s data-driven approach enables prenatal care teams to identify high-risk pregnancies early and intervene to prevent complications.
“This funding marks a significant milestone in Delfina’s fulfillment of our mission to solve the national maternal health crisis,” said Senan Ebrahim, MD, PhD, CEO and Founder of Delfina. “We are grateful for the support of our investors and partners who share our commitment to improving outcomes for moms and babies. With this capital, Delfina will accelerate serving diverse populations, scale our impact nationally, and evolve our market-leading AI-powered predictive technology to continue delivering proven results for our partners nationwide.”
Evidence-Based Proven Impact
Delfina’s evidence-based approach has demonstrated measurable success in improving maternal and infant health outcomes. Partners have observed reductions in preterm births, NICU admissions, hypertensive disorders, and gestational diabetes, leading to significant cost savings for health plans. Based on these improved outcomes, Delfina guarantees 3X cost savings for health plans.
“Since we transformed our practice with Delfina Care, we have seen the positive impact on our pregnant patients’ care every day,” said Fatimah Lalani, DO, Chief Medical Officer of HOPE Clinic in Houston, Texas. “We see many patients whose cardiovascular and metabolic challenges we can now proactively manage thanks to Delfina’s insights. Our clinicians have been empowered by Delfina’s system to efficiently provide a new level of proactive care for healthy pregnancy outcomes.”
